Clinical Trial Detail

NCT ID NCT02487459
Title Safety Study of Gene Modified Donor T-Cells in Adults With Advanced Hematologic Malignancies
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Bellicum Pharmaceuticals
Indications

chronic myeloid leukemia

acute lymphoblastic leukemia

acute myeloid leukemia

myelodysplastic syndrome

non-Hodgkin lymphoma

Therapies

BPX-501

Rimiducid

Age Groups: adult

Additional content available in CKB BOOST